Prior Authorization Changes: Will AI Be Enough to Ease the Burden?
The Centers for Medicare & Medicaid Services (CMS) has proposed new rules aimed at reforming prior authorization processes for drugs, a significant shift that will directly impact revenue cycle management (RCM) teams. These changes could streamline workflows and reduce administrative burdens, underscoring the need for RCM professionals to adapt quickly to maintain financial health amid evolving regulations.
What's Actually Happening
CMS's proposed rule seeks to improve the prior authorization process, which has long been criticized for being cumbersome and time-consuming. Specifically, the rule aims to standardize data requirements and enhance the electronic exchange of prior authorization information between payers and providers. This initiative is part of a broader effort to reduce delays in patient care and enhance administrative efficiency within the healthcare system. By simplifying prior authorization for drugs, CMS hopes to alleviate some of the burdens that healthcare providers face, potentially leading to faster treatment for patients.
Free Daily RCM Intelligence
Denial trends, payer policy moves, vendor intel — delivered every morning. Free.